Xie Mingxing, Chou Yi-Hong, Zhang Li, Zhang Danqing, Tiu Chui-Mei
Department of Ultrasound, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
J Med Ultrasound. 2021 Mar 20;29(1):3-8. doi: 10.4103/JMU.JMU_140_20. eCollection 2021 Jan-Mar.
The outbreak of the SARS-CoV-2 infection, also known as coronavirus disease 2019 (COVID-19), was formally defined a pandemic by the World Health Organization (WHO) in March 2020, and is still a global health issue. Since there is a high prevalence of acute cardiac injury in patients with COVID-19 infection, point-of-care cardiac ultrasound (PoCCUS) may be used for longitudinal monitoring of patients infected with COVID-19. However, there is still limited experience on the application of PoCCUS in the COVID-19 pandemic. Within the point of care setting in our system, focused cardiac US exams were performed with specific imaging protocols on the basis of suspicion of a specific disease, such as ruling out tamponade or thrombotic complications. Our preliminary experience shows that PoCCUS helps distinguish the causes of dyspnea in febrile patients. The COVID-19 infection may play a role in unmasking or exacerbating underlying chronic cardiovascular conditions, especially in patients with inadequate past history. In hospitalized patients with COVID-19, CURB-65 score for pneumonia severity and raised D-dimer were significantly associated with deep vein thrombosis (DVT). COVID-19 patients with DVT had worse prognosis, and patients with lower leg edema deserve further evaluation by using point-of-care ultrasound for the lower legs and heart. In COVID-19 patients with arrhythmia, PoCCUS used by experienced hands may reveal abnormal right ventricle (RV) functional parameters and lead to a more comprehensive cardiac US study. When there is suspicion of cardiac disease, PoCCUS can be done first, and if information is inadequate, limited transthoracic echocardiography (TTE), and critical care echocardiography (CCE) can be followed. Ultrasound practitioners should follow the standard precautions for COVID-19 as outlined by the Centers for Disease Control and Prevention to prevent transmission of infection, regardless of suspected or confirmed COVID-19.
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染,即2019冠状病毒病(COVID-19),于2020年3月被世界卫生组织(WHO)正式定义为大流行病,至今仍是一个全球健康问题。由于COVID-19感染患者中急性心脏损伤的患病率较高,床旁心脏超声(PoCCUS)可用于对COVID-19感染患者进行纵向监测。然而,PoCCUS在COVID-19大流行中的应用经验仍然有限。在我们系统的床旁检查环境中,基于对特定疾病的怀疑,如排除心包填塞或血栓并发症,采用特定的成像方案进行重点心脏超声检查。我们的初步经验表明,PoCCUS有助于鉴别发热患者呼吸困难的原因。COVID-19感染可能在揭示或加重潜在的慢性心血管疾病方面起作用,尤其是在既往病史不充分的患者中。在住院的COVID-19患者中,肺炎严重程度的CURB-65评分和D-二聚体升高与深静脉血栓形成(DVT)显著相关。患有DVT的COVID-19患者预后较差,小腿水肿的患者值得通过对小腿和心脏进行床旁超声进一步评估。对于患有心律失常的COVID-19患者,经验丰富的人员使用PoCCUS可能会发现右心室(RV)功能参数异常,并导致更全面的心脏超声检查。当怀疑有心脏疾病时,可先进行PoCCUS检查,如果信息不足,可随后进行有限的经胸超声心动图(TTE)和重症监护超声心动图(CCE)检查。超声从业者应遵循疾病控制与预防中心概述的针对COVID-19的标准预防措施,以防止感染传播,无论患者是疑似还是确诊COVID-19。